HomeRecall LibraryMedication RecallsFDA warns about possible increased risk of death and serious side effects with cancer drug Copiktra (duvelisib)
FDA recall notice

FDA warns about possible increased risk of death and serious side effects with cancer drug Copiktra (duvelisib)

FDA warns about possible increased risk of death and serious side effects with cancer drug Copiktra (duvelisib)

What to do next

Read the issuing agency's notice carefully, compare the product identifiers, and follow the official remedy instructions. RecallDefense helps you keep watch, but the source agency's notice is the authority for action.

View source notice

Source attribution: FDA. Published Jun 30, 2022.

Continue Exploring Recall Coverage

Keep Watch After Today

Save a product and get notified when a new recall matches it.

Start Monitoring Free